Delivering Value To Those We Serve

Overview

Recent News

Date Title and Summary
Toggle Summary Assertio Therapeutics Announces Exchange Offer of $200 Million of its Currently Outstanding 2.50% Convertible Notes Due 2021
LAKE FOREST, Ill. , Aug. 09, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) (“Assertio”) today announced it has entered into separate, privately negotiated exchange agreements (the “Exchange Agreements”) with a limited number of holders of Assertio’s currently outstanding 2.50%
Toggle Summary Assertio Therapeutics Announces Strong Second-Quarter 2019 Results
-- Reports Total Company GAAP Net Sales of $57.2 million , Total Company Non-GAAP Net Sales of $59.3 million , including Commercialization Agreement Revenues of $31.0 million -- -- Drives Continued Improvement in Operating Efficiencies as the Company  Executes on its Ongoing Transformation -- --
Toggle Summary Assertio Therapeutics to Report Second Quarter 2019 Financial Results After The Close of Markets on Wednesday, August 7, 2019
LAKE FOREST, Ill. , July 17, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ:ASRT) today announced that it will release second quarter 2019 financial results on Wednesday, August 7, 2019 , after the close of markets. Following the announcement, the Company will host a conference call

Upcoming Events

There are currently no events to display.

Recent SEC Filings

Filing date Description Form Filing Group View

Amendment to a previously filed SC TO-T

SC TO-T/A
Mergers & Acquisitions
View HTML

Amendment to a previously filed SC TO-T

SC TO-T/A
Mergers & Acquisitions
View HTML

Amendment to a previously filed SC TO-T

SC TO-T/A
Mergers & Acquisitions
View HTML

Amendment to a previously filed SC TO-T

SC TO-T/A
Mergers & Acquisitions
View HTML

Amendment to a previously filed SC TO-T

SC TO-T/A
Mergers & Acquisitions
View HTML

IR Contact

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
Phone: 800.509.5586
http://www.continentalstock.com
 

Independent Registered Public Accounting Firm

Ernst & Young LLP
Palo Alto, CA
 

Investor Relations Contact

John B. Thomas
SVP, Investor Relations & Corporate Communications
jthomas@assertiotx.com